Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Akrosite
- Development stage
- Unknown
- Lead developer
- Akrovis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Akrosite is a dietary supplement marketed by Akrovis Pharmaceuticals, a consumer healthcare company based in Mumbai, India. Formulated as oral gummies, the product is positioned for the support of eye health and vision. It typically contains a blend of carotenoids and vitamins, such as lutein and zeaxanthin, which are intended to provide antioxidant protection to the retina and support macular health. As a product of a generic and OTC pharmaceutical company, Akrosite is a commercial nutraceutical and is not associated with a clinical-stage drug development pipeline or specific therapeutic molecular targets.
- Brand names
- Akrosite
- Other names
- Akrosite gummies
Beyond the preview
Go deeper on Akrosite.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akrosite.